Multimedia Available: Corixa Appoints Industry Veteran to Lead BEXXAR Sales and Future Commercialization Efforts

Business Wire,  Sept 23, 2003  

• E-mail
• Print
• Link

Business Editors/Health/Medical Writers

ADVISORY...for Tuesday (Sept. 23)

NOTE TO EDITORS: Multimedia Assets Available With This Story

Include Logos, Photos, Text News Releases

--(BUSINESS WIRE)

Corixa Corp. (Nasdaq:CRXA), a leading provider of immunotherapeutics, today announced it has appointed Chris E. Rivera as vice president of sales. In this new position, Mr. Rivera will grow and lead Corixa's U.S. sales efforts for BEXXAR(R), the company's novel radioimmunotherapy for follicular non-Hodgkin's lymphoma (NHL), which the company announced was approved by the U.S. Food and Drug Administration on June 30, 2003.

You can reach the story directly by going to http://www.newstream.com/cgi-bin/display_story.cgi?10724

This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics and photos.

If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com.

COPYRIGHT 2003 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning